Indefinite Delivery Contract 75N92019D00041

Award Date 9/20/19
Last Date to Order 9/19/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The University of North Carolina at Chapel Hill (UNC) has been awarded a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services. The $146.3 million contract has a period of performance through July 2031 and aims to provide pre-clinical research services to develop and refine animal and animal replacement models for evaluating potential...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. This $146.3 million contract has a 7-year ordering period and covers four task areas: small animal models, non-human primate models, animal replacement and non-traditional animal models, and...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $40 million indefinite delivery contract (IDC) by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to provide pre-clinical research services related to infectious disease models. This IDC, part of NIAID's "Preclinical Models of Infectious Diseases 2017-2024" program, allows UNC-CH to execute task orders for a variety of research services...
The University of North Carolina at Chapel Hill (UNC), through its Office of Sponsored Research, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services. The contract, valued at $22,004,772, has a period of performance through November 14, 2029. Under this IDC, UNC is serving as the coordinating center for the Atherosclerosis Risk in Communities (ARIC) Study, a...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded this $107,274,471 Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the University of North Carolina at Chapel Hill (UNC-CH) to provide preclinical development support for candidate products and drug development activities related to infectious diseases like HIV, hepatitis, and tuberculosis. The contract encompasses a wide range of services including in...
This single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH) to operate the Coordinating Center for the Hispanic Community Health Study - Study of Latinos (HCHS-SOL). The $35 million IDIQ contract has an ultimate completion date of November 29, 2033. Under this contract, UNC-CH will provide core study...
This federal Indefinite Delivery Contract (IDC) was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-CH) to support the Atherosclerosis Risk in Communities (ARIC) study. The $5,998,555 single-award IDC has a period of performance through November 2022 and provides research services and operational support for the ARIC study's...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of North Texas Health Science Center at Fort Worth (UNTHSC) as a single award with a $146,300,000 ceiling value and a period of performance through July 2031. The contract is for the provision of pre-clinical models of infectious diseases, including the development and refinement of small animal, non-human primate, and animal...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded this $146.3 million single award Indefinite Delivery Contract to the University of Louisville to provide preclinical models of infectious diseases over a 7-year ordering period ending in 2031. The contract supports NIAID's mission to facilitate research on understanding, treating, and preventing infectious diseases by enabling the development and refinement of small animal, non-human primate, and non-traditional animal...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. Department of Health and Human Services, awarded an $8,899,219 Indefinite Delivery Contract (IDC) to the University of Mississippi Medical Center (UMMC) to provide a Training and Education Center (TEC) for cardiovascular epidemiology and related biomedical research. This IDC supports NHLBI's long-running Jackson Heart Study (JHS) program, which examines cardiovascular disease risk factors and outcomes, with a...
  • 75N92019D00041
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the University of North Carolina at Chapel Hill (UNC-CH) to provide preclinical research services for infectious disease studies. This $146.3 million single-award IDIQ runs through July 2031 and covers work in developing and refining animal models to evaluate potential vaccines, therapeutics, and diagnostics. Task areas include small animal models, non-human primate models, alternative models, and production of specialized reagents.

Separately, NHLBI has awarded several delivery order contracts to UNC-CH under this IDIQ, totaling over $10 million, to maintain a colony of research animals with bleeding disorders and develop a bispecific monoclonal antibody. The contracts, which do not utilize small business set-asides, are for research support services to aid NHLBI in advancing medical treatments for cardiovascular, pulmonary, and blood disorders. The work is performed at UNC-CH's facilities in Chapel Hill, North Carolina.

Generated 10/22/24, 9:04 AM